WAAVP Logo

Emily JenkinsSpeaker Biography

Richard Martin

Richard J. Martin, BVSc, PhD, DSc, DipECVPT, MRCVS
Professor of Pharmacology, Department of Biomedical Sciences, Iowa State University,
Ames, IA 50011
Phone: 515-294-2470
Email: rjmartin@iastate.edu

  • Went to Liverpool Veterinary School and Qualified BVSc, MRCVS
  • Interest was stimulated in the Nervous System by Prof Tony King (Vet Anatomy)
  • Pursued a PhD studying electrophysiology of the CNS
  • Influenced by Dr Alan Knifton (Liverpool University Pharmacology) and took a Lectureship at R(D)SVS, Edinburgh University in pharmacology
  • Developed a research interest and published on the modes of action of anthelmintic drugs that have effects on membrane ion-channels (piperazine, diethylcarbamazine, levamisole, pyrantel, morantel, emodepside)
  • Promoted Reader and then Professor at University of Edinburgh before joining the Department of Biomedical Sciences at Iowa State University, USA
  • Research interests: Development of novel anthelmintics, modes of action of anthelmintics and mechanisms of anthelmintic resistance.

Abstract Submission

Anthelmintics: The Best Way to Predict the Future is to Create it

Richard J. Martin, Alan P. Robertson, S. Verma, Shivani Choudhary, Sudhanva Kashyap, Melanie Abongwa and Fudan Zheng

Department of Biomedical Sciences, Iowa State University, Ames, IA 50011, USA

We can predict aspects of the future by creating new knowledge. When we look at drugs that are used to control parasites, we see that there is new knowledge about their mode of action and this knowledge is predicted to allow us to put combinations of drugs together more rationally to increase the spectrum of action and to slow the development of anthelmintic resistance. In this paper we comment on some recent observations of ours on the modes of action of emodepside, diethylcarbamazine and tribendimidine. Emodepside increases the activation of a SLO-1 K current inhibiting movement, and diethylcarbamazine has a synergistic effect on the effect of emodepside on the SLO-1 K current, increasing the size of the response. The combination may be considered for further testing for therapeutic use. Tribendimidine is a selective cholinergic nematode B-subtype nAChR agonist, producing muscle depolarization and contraction. It has different subtype selectivity to levamisole and may be effective in the presence of some types of levamisole resistance. The new information about the modes of action may aid the design of rational drug combinations designed to slow the development of resistance or increase the spectrum of action.

Sponsors Logos Bayer: Science for a Better Life Elanco Virbac: Passionate about animal health Norbrook: The only home-grown British pharmaceutical company MSD Animal Health Merial UK Zoetis, the largest global animal health company AAC Liverpool: Where Liverpool Welcomes the World University of Liverpool AAC Liverpool: Where Liverpool Welcomes the World Moredun